China Pharma Holdings, Inc. SEC filings CPHI

China Pharma Holdings, Inc. has 426 filings in SEC EDGAR's recent list, going back to Feb 15, 2000. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 22, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

China Pharma Holdings, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Other events
Jul 22, 2026 Jul 22, 2026
8-K Current report
Material agreement, Unregistered share sale
Mar 3, 2026 Feb 26, 2026
8-K Current report
Material agreement, Unregistered share sale
Feb 10, 2026 Feb 5, 2026
8-K Current report
Shareholder vote results
Jan 6, 2026 Dec 30, 2025
8-K Current report
Material agreement, Unregistered share sale
Dec 23, 2025 Dec 22, 2025
8-K Current report
Material agreement, Unregistered share sale
Dec 10, 2025 Dec 4, 2025
8-K Current report
Regulation FD disclosure
Apr 4, 2025 Apr 4, 2025
8-K Current report
Agreement ended
Dec 26, 2024 Dec 23, 2024
8-K Current report
Shareholder vote results
Dec 26, 2024 Dec 22, 2024
8-K Current report
Material agreement
Dec 13, 2024 Dec 12, 2024
8-K Current report
Material agreement
May 30, 2024 May 23, 2024
8-K Current report
Auditor change
May 8, 2024 May 7, 2024
8-K Current report
Other events
Mar 29, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure
Feb 23, 2024 Feb 23, 2024
8-K Current report
Material agreement, Unregistered share sale
Feb 8, 2024 Feb 2, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 21, 2023 Dec 15, 2023
8-K Current report
Shareholder vote results, Other events
Dec 19, 2023 Dec 15, 2023
8-K Current report
Listing notice
Oct 3, 2023 Sep 27, 2023
8-K Current report
Material agreement
Apr 20, 2023 Apr 13, 2023
8-K Current report
Other events
Mar 29, 2023 Mar 27, 2023
8-K Current report
Regulation FD disclosure
Feb 24, 2023 Feb 24, 2023
8-K Current report
Shareholder vote results
Dec 30, 2022 Dec 27, 2022
8-K Current report
Material agreement, Unregistered share sale
Dec 2, 2022 Nov 28, 2022
8-K Current report
Listing notice
Dec 2, 2022 Dec 1, 2022
8-K Current report
Listing notice
Sep 30, 2022 Sep 26, 2022
8-K Current report
Listing notice
Jun 22, 2022 Jun 15, 2022
8-K Current report
Shareholder vote results
Dec 29, 2021 Dec 26, 2021
8-K Current report
Material agreement, New debt
Nov 23, 2021 Nov 17, 2021
8-K Current report
Officer or director change
Sep 15, 2021 Sep 9, 2021
8-K Current report
Officer or director change, Shareholder vote results
Dec 29, 2020 Dec 23, 2020
8-K Current report
Shareholder vote results
Dec 23, 2019 Dec 19, 2019
8-K Current report
Shareholder vote results
Dec 6, 2018 Dec 4, 2018
8-K Current report
Other events
Mar 12, 2018 Mar 6, 2018
8-K Current report
Shareholder vote results
Dec 18, 2017 Dec 14, 2017
8-K Current report
Listing notice
Sep 12, 2017 Sep 6, 2017
8-K Current report
Results of operations
Mar 31, 2017 Mar 31, 2017
8-K Current report
Other events
Dec 28, 2016 Dec 22, 2016
8-K Current report
Shareholder vote results
Dec 13, 2016 Dec 8, 2016
8-K Current report
Auditor change
Dec 2, 2016 Nov 28, 2016
8-K Current report
Restatement
Dec 11, 2015 Dec 8, 2015
8-K Current report
Shareholder vote results
Dec 10, 2015 Dec 8, 2015
8-K Current report
Shareholder vote results
Dec 31, 2014 Dec 29, 2014
8-K Current report
Shareholder vote results
Dec 17, 2013 Dec 16, 2013
8-K Current report
Auditor change
Oct 15, 2013 Oct 10, 2013
8-K Current report
Auditor change
Sep 4, 2013 Sep 1, 2013
8-K Current report
Material agreement, Change to shareholder rights
Jan 4, 2013 Dec 31, 2012
8-K Current report
Shareholder vote results
Dec 26, 2012 Dec 21, 2012
8-K Current report
Officer or director change
Apr 30, 2012 Sep 30, 2011
8-K Current report
Restatement
Mar 2, 2012 Feb 28, 2012
8-K Current report
Shareholder vote results
Dec 30, 2011 Dec 22, 2011
8-K Current report
Officer or director change
Jun 1, 2011 May 25, 2011
8-K Current report
Shareholder vote results
Dec 29, 2010 Dec 22, 2010
8-K Current report
Other events
Oct 1, 2009 Oct 1, 2009
8-K Current report
Officer or director change
Sep 4, 2009 Sep 4, 2009
8-K Current report
Other events
Aug 28, 2009 Aug 28, 2009
8-K Current report
Officer or director change
Apr 30, 2009 Apr 30, 2009
8-K Current report
Unregistered share sale
Dec 29, 2008 Dec 24, 2008
8-K Current report
Unregistered share sale
Jun 27, 2008 Jun 27, 2008
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 28, 2008 May 28, 2008
8-K Current report
Results of operations, Other events
Feb 28, 2008 Feb 25, 2008
8-K Current report Feb 4, 2008 Feb 1, 2008
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 6, 2007 Feb 1, 2007
8-K Current report
Results of operations
Sep 21, 2006 Sep 6, 2006
8-K Current report
Officer or director change
May 4, 2006 May 3, 2006
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control
Oct 20, 2005 Oct 19, 2005
8-K Current report
Auditor change
Aug 18, 2005 Aug 17, 2005
8-K Current report
Unregistered share sale, Change in control, Officer or director change
May 11, 2005 May 11, 2005
8-K Current report
Agreement ended, Other events
Mar 29, 2005 Jan 14, 2005
8-K/A Amended current report
Material agreement
Oct 4, 2004 Apr 17, 2004
8-K Current report Aug 20, 2004 Aug 17, 2004
8-K/A Amended current report Mar 9, 2004 Feb 4, 2004
8-K Current report Feb 6, 2004 Feb 4, 2004
8-K Current report Aug 18, 2003 Aug 13, 2003
8-K Current report Sep 11, 2002 Sep 5, 2002
8-K/A Amended current report Oct 26, 2001 Jul 24, 2001
8-K Current report Aug 27, 2001 Aug 21, 2001
8-K Current report Aug 8, 2001 Jul 24, 2001

Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPHI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hainan Province, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1106644
Former names
TS ELECTRONICS INC (until May 4, 2006); SOFTSTONE INC (until Aug 18, 2003); SOFTSTONE INC /DE/ (until Jan 27, 2003); KILKENNY ACQUISITION CORP (until Mar 30, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.